The Short Version
Treatment advances in multiple myeloma are real and significant, but the claim that the disease is "nearly curable" materially overstates the medical consensus as of April 2026. The most authoritative sources — including Memorial Sloan Kettering (January 2026) and Indiana University Cancer Center — explicitly state myeloma remains incurable. Cure-like outcomes such as deep remission and MRD negativity apply only to specific patient subsets under specific regimens, and relapse remains common across the broader population.